// App-Quantinova.ai

: Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification

Researchers

Presenter

  • Nikolaos I. Kanellakis

Principal Investigators

  • Rachelle Asciak

  • Xuan Yao

  • Yanchun Peng

  • Mark Mccole

  • Simon Mcgowan

  • Rachel Mercer

  • Rob Hallifax

  • Taylor Sherrill

  • Fabien Maldonado

  • Daniel Ebner

  • Timothy S. Blackwell

  • Georgios T Stathopoulos

  • Tao Dong

  • Najib M Rahman

  • Ioannis Psallidas

Medical Centers

  • Laboratory of Pleural and Lung Cancer Translational Research, University of Oxford, Oxford, United Kingdom

  • Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  • Cardiovascular and Respiratory Pathology, Cellular Pathology, Oxford University hospitals, Oxford, United Kingdom

  • MRC Centre for Computational Biology, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  • Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, Oxford, United Kingdom

  • Pulmonary Division, Vanderbilt University, Nashville, United States of America

  • Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK

  • Laboratory of Molecular Respiratory Carcinogenesis, Deprtment of Physiology, Faculty of Medicine, University of Patras, Patras, Greece

Locations

  • United Kingdom

  • United States

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Malignant pleural mesothelioma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved